148 related articles for article (PubMed ID: 2013839)
1. Physiologic and metabolic influences on enterohepatic recirculation: simulations based upon the disposition of valproic acid in the rat.
Pollack GM; Brouwer KL
J Pharmacokinet Biopharm; 1991 Apr; 19(2):189-225. PubMed ID: 2013839
[TBL] [Abstract][Full Text] [Related]
2. Hepatobiliary disposition of valproic acid and valproate glucuronide: use of a pharmacokinetic model to examine the rate-limiting steps and potential sites of drug interactions.
Booth CL; Pollack GM; Brouwer KL
Hepatology; 1996 Apr; 23(4):771-80. PubMed ID: 8666331
[TBL] [Abstract][Full Text] [Related]
3. Probenecid-associated alterations in valproate glucuronide hepatobiliary disposition: mechanistic assessment using mathematical modeling.
Ward ES; Pollack GM; Brouwer KL
J Pharmacol Exp Ther; 2001 Apr; 297(1):141-7. PubMed ID: 11259538
[TBL] [Abstract][Full Text] [Related]
4. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats.
Yamamura N; Imura K; Naganuma H; Nishimura K
Drug Metab Dispos; 1999 Jun; 27(6):724-30. PubMed ID: 10348803
[TBL] [Abstract][Full Text] [Related]
5. Probenecid-associated alterations in valproic acid pharmacokinetics in rats: can in vivo disposition of valproate glucuronide be predicted from in vitro formation data?
Ward ES; Pollack GM; Brouwer KL
Drug Metab Dispos; 2000 Dec; 28(12):1433-9. PubMed ID: 11095580
[TBL] [Abstract][Full Text] [Related]
6. Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates.
Tang W; Abbott FS
Chem Res Toxicol; 1996 Mar; 9(2):517-26. PubMed ID: 8839057
[TBL] [Abstract][Full Text] [Related]
7. Protein binding and hepatobiliary distribution of valproic acid and valproate glucuronide in rats.
Brouwer KL; Hall ES; Pollack GM
Biochem Pharmacol; 1993 Feb; 45(3):735-42. PubMed ID: 8442771
[TBL] [Abstract][Full Text] [Related]
8. Concentration-dependent disposition of glucuronide metabolite of valproate.
Yu HY; Shen YZ
J Pharm Pharmacol; 2002 May; 54(5):633-9. PubMed ID: 12005358
[TBL] [Abstract][Full Text] [Related]
9. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect.
Dickinson RG; Harland RC; Ilias AM; Rodgers RM; Kaufman SN; Lynn RK; Gerber N
J Pharmacol Exp Ther; 1979 Dec; 211(3):583-95. PubMed ID: 390116
[TBL] [Abstract][Full Text] [Related]
10. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
Watkins JB; Klaassen CD
J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642
[TBL] [Abstract][Full Text] [Related]
11. Impaired biliary elimination of beta-glucuronidase-resistant "glucuronides" of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers.
Dickinson RG; Kluck RM; Wood BT; Eadie MJ; Hooper WD
Drug Metab Dispos; 1986; 14(2):255-62. PubMed ID: 2870903
[TBL] [Abstract][Full Text] [Related]
12. Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits.
Yokogawa K; Iwashita S; Kubota A; Sasaki Y; Ishizaki J; Kawahara M; Matsushita R; Kimura K; Ichimura F; Miyamoto K
Pharm Res; 2001 Sep; 18(9):1320-6. PubMed ID: 11683247
[TBL] [Abstract][Full Text] [Related]
13. Steady-state dispositions of valproate and diflunisal alone and coadministered to healthy volunteers.
Addison RS; Parker-Scott SL; Eadie MJ; Hooper WD; Dickinson RG
Eur J Clin Pharmacol; 2000 Dec; 56(9-10):715-21. PubMed ID: 11214782
[TBL] [Abstract][Full Text] [Related]
14. Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride.
Khemawoot P; Maruyama C; Tsukada H; Noda H; Ishizaki J; Yokogawa K; Miyamoto K
Biopharm Drug Dispos; 2007 Sep; 28(6):331-8. PubMed ID: 17617793
[TBL] [Abstract][Full Text] [Related]
15. Disposition and protein binding of valproic acid in the developing rat.
Haberer LJ; Pollack GM
Drug Metab Dispos; 1994; 22(1):113-9. PubMed ID: 8149869
[TBL] [Abstract][Full Text] [Related]
16. Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid.
Lee SY; Huh W; Jung JA; Yoo HM; Ko JW; Kim JR
Drug Des Devel Ther; 2015; 9():4559-63. PubMed ID: 26309401
[TBL] [Abstract][Full Text] [Related]
17. Absence of phenolic glucuronidation and enhanced hydroxylation of diflunisal in the homozygous Gunn rat.
Dickinson RG; Verbeeck RK; King AR
Xenobiotica; 1991 Nov; 21(11):1535-46. PubMed ID: 1763527
[TBL] [Abstract][Full Text] [Related]
18. Effect of naproxen co-administration on valproate disposition.
Addison RS; Parker-Scott SL; Hooper WD; Eadie MJ; Dickinson RG
Biopharm Drug Dispos; 2000 Sep; 21(6):235-42. PubMed ID: 11304722
[TBL] [Abstract][Full Text] [Related]
19. Elimination of diflunisal as its acyl glucuronide, phenolic glucuronide and sulfate conjugates in bile-exteriorized and intact rats.
Dickinson RG; King AR; Verbeeck RK
Clin Exp Pharmacol Physiol; 1989 Dec; 16(12):913-24. PubMed ID: 2612067
[TBL] [Abstract][Full Text] [Related]
20. Effect of phenobarbital and p-hydroxyphenobarbital glucuronide on acetaminophen metabolites in isolated rat hepatocytes: use of a kinetic model to examine the rates of formation and egress.
Studenberg SD; Brouwer KL
J Pharmacokinet Biopharm; 1993 Apr; 21(2):175-94. PubMed ID: 8229679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
